What is Swoop?
Swoop operates at the intersection of healthcare, artificial intelligence, and marketing, aiming to enhance patient understanding of diseases and treatment options. The company's HIPAA-certified system leverages AI and machine learning, analyzing a vast dataset of over 300 million de-identified patients and 65 billion anonymous consumer interactions. This enables Swoop to identify unique patient audiences and activate them through cross-channel marketing, ultimately driving better patient engagement and Rx lift. Their approach is designed to make patients active participants in their healthcare journey.
How much funding has Swoop raised?
Swoop has raised a total of $13.4M across 4 funding rounds:
Series A
$4.8M
Other Financing Round
$3M
Series B
$3.5M
Debt
$2.1M
Series A (2011): $4.8M with participation from General Catalyst Partners, US Venture Partners, and Valhalla Partners
Other Financing Round (2012): $3M led by U.S. Venture Partners and Valhalla Partners
Series B (2013): $3.5M supported by U.S. Venture Partners
Debt (2014): $2.1M featuring U.S. Venture Partners
Key Investors in Swoop
U.S. Venture Partners
U.S. Venture Partners (USVP) is a prominent Silicon Valley venture capital firm specializing in early-stage investments across sectors like cybersecurity, enterprise software, consumer products, and healthcare. They leverage a strong network to support company strategy and scaling.
Valhalla Partners
Valhalla Partners is a venture capital firm focused on building technology companies by working closely with entrepreneurs, offering seasoned advice and best practices developed over two decades.
General Catalyst Partners
General Catalyst is a venture capital firm that backs entrepreneurs and management teams with ambitious visions, focusing on transformational business opportunities across various sectors including technology and healthcare.
What's next for Swoop?
With substantial enterprise-level funding and a recent strategic investment, Swoop is poised for accelerated growth and market expansion. The company's focus on data-driven patient engagement and its advanced AI capabilities position it as a key player in transforming how pharmaceutical companies connect with patients and healthcare providers. Future developments are likely to involve further refinement of their AI algorithms, expansion of their data universe, and the forging of new strategic partnerships to broaden their reach within the pharmaceutical and healthcare ecosystems. This strategic financing will fuel innovation and solidify Swoop's leadership in patient-centric healthcare marketing.
See full Swoop company page
